Abeona Therapeutics Inc. (NASDAQ: $ABEO) is a clinical-stage biopharmaceutical company developing gene therapies for life-threatening rare genetic diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups.

Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases.

For more information, please visit our website at www.abeonatherapeutics.com